Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

NCT05645887 is registered in ClinicalTrials.gov with Albimmune SL as lead sponsor.

NCT NCT05645887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05645887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
Lead sponsor
Albimmune SL
Phase
Phase 2
Overall status
Withdrawn
Start date
February 29, 2024
Completion date
May 23, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock